Zenas BioPharma (ZBIO) IPO deck
Zenas BioPharma is a clinical-stage global biopharmaceutical company developing innovative immune-based therapies for autoimmune diseases, with a focus on advancing first- and best-in-class therapeutics like Obexelimab.